EUVIMEDEUVIMED entdecken
Crossref

Study on mechanisms and features of bone metastasis for breast cancer: a narrative review

Mengyu Ding, Zhanhong Chen, Huanhuan Zhou, Xiaojia Wang

Breast Communications · 2025

DOI: 10.21037/bc-25-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Communications, 2025. Verfasst von Mengyu Ding und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Breast cancer bone metastasis (BCBM) can lead to severe complications (e.g., bone pain, fractures, spinal cord compression), significantly impacting quality of life. Understanding its pathophysiology and clinical features is crucial for precise diagnosis and personalized treatment. The disease displays distinct organotropism with unclear regulatory mechanisms, and lacks reliable early biomarkers. By describing and integrating basic and clinical research findings, this study aims to provide a comprehensive reference for exploring the mechanisms of BCBM and improving clinical diagnosis and treatment, ultimately enhancing patient outcomes.

Methods

We searched PubMed and China National Knowledge Infrastructure (CNKI) for English and Chinese publications published between January 1, 1987 and August 23, 2025. Leveraging our research team’s expertise in tumor metastasis, we analyzed the molecular mechanisms, clinical characteristics, and therapeutic approaches for BCBM. Key Content and Findings: The pathogenic mechanism of BCBM is currently understood to involve three critical phases: establishment of the pre-metastatic niche (PMN), extravasation and homing of tumor cells, followed by dormancy and subsequent reactivation of metastatic foci. Based on distinct radiographic features, bone metastases are classified into three subtypes: osteolytic, osteoblastic, and mixed lesions. Notably, osteolytic and osteoblastic lesions demonstrate different molecular mechanisms and clinical characteristics. Bone-modifying agents (BMAs) represent a crucial component in the management of osseous metastases. The current pharmacotherapeutic options primarily consist of bisphosphonates and denosumab. Additionally, bone turnover biomarkers exhibit both diagnostic correlation and prognostic significance, while serving as valuable indicators for identifying patients at high risk of skeletal-related events (SREs).

Conclusions

BCBM leads to SREs that severely compromise patients’ quality of life through complex tumor cell-bone microenvironment interactions. Current clinical management relies on BMAs targeting osteoclast activity, while bone metabolism biomarkers provide prognostic value. However, significant challenges remain in fully understanding the molecular drivers of metastasis. Future research must focus on elucidating key pathogenic mechanisms, developing reliable biomarkers, and discovering more effective therapies to ultimately improve outcomes for this patient population.

Zitieren

APA

Ding, M., Chen, Z., Zhou, H., & Wang, X. (2025). Study on mechanisms and features of bone metastasis for breast cancer: a narrative review. Breast Communications. https://doi.org/10.21037/bc-25-7

Vancouver

Ding M, Chen Z, Zhou H, Wang X. Study on mechanisms and features of bone metastasis for breast cancer: a narrative review. Breast Communications. 2025. doi:10.21037/bc-25-7

BibTeX
@article{Ding2025,
  author = {Ding, Mengyu and Chen, Zhanhong and Zhou, Huanhuan and Wang, Xiaojia},
  title = {Study on mechanisms and features of bone metastasis for breast cancer: a narrative review},
  journal = {Breast Communications},
  year = {2025},
  doi = {10.21037/bc-25-7}
}
Kostenlos starten →